Navigation Links
Flynn Pharma Acquires Rights From Pacira Pharmaceuticals to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe
Date:9/27/2007

HITCHIN, England, and SAN DIEGO, Sept. 27 /PRNewswire/ -- Flynn Pharma Limited, a specialty pharmaceutical company focused on acquiring and commercializing proprietary products in secondary healthcare and related markets, today announced it has acquired exclusive marketing and distribution rights to DepoDur(R) (morphine sulphate extended release liposome injection) for Europe and a number of other markets from San Diego-based Pacira Pharmaceuticals.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070618/PACIRALOGO)

Pacira Pharmaceuticals, a former business unit of SkyePharma, PLC, is an independent private company focused on developing and manufacturing controlled-release injectable products based on their DepoFoam(R) and Biosphere(R) drug delivery platforms.

DepoDur, which utilizes the DepoFoam technology, is a novel, single dose extended-release formulation of morphine. A single injection of DepoDur into the lumbar epidural space may provide pain relief for up to 48 hours following major surgery without the restrictions and potential complications associated with an indwelling epidural catheter. DepoDur is the only opioid approved in Europe (UK, MHRA, 2006) for epidural use. In the US, DepoDur is marketed by EKR Therapeutics, Inc.

"We are pleased to add an innovative product like DepoDur to our growing hospital product portfolio." said David Walters, Director of Flynn. "DepoDur is consistent with, and complementary to, our model of adding products for the secondary healthcare markets."

Fred Middleton, Pacira's Chairman of the Board commented, "In DepoDur, Flynn Pharma will have a new foundation on which to continue building their hospital franchise. Through the use of Pacira's extended-release injectable technology, DepoFoam, DepoDur supports the sustained release of epidural morphine to provide up to 48 hours of post-surgery pain relief, when most
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. India to benefit from pharma companies move
2. South Africa Wins landmark case against pharmaceutical giants
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
5. Pharma cos must forge Strategic alliances
6. Jharkhand Pharmacies Refuse To Sell Viagra
7. Setting up a new pharmaceutical industry in India
8. Medicis Pharmaceutical company enters pediatric market
9. Supply of Radiopharmaceuticals Hampered by Attacks
10. Pharma majors gear to supply anti-anthrax drug
11. Pharmacies in for a dose of bitter medicine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Bringing in the New Year tradit...be better and take better self-care. What to do to...in the focus toward goals for 2010? It’s ea...ve safe skin care is the primary mission. It isn,t...database, a popular consumer guide to safe cosmeti...
(Date:12/2/2009)... Links Medical Products Inc., an...als and nursing homes, announces the opening of it... facility is located at 9247 Research Drive, Irvin...intains another facility in the Irvine Spectrum pl..., California. This most recent expansion reflects ...
(Date:12/2/2009)... myEMRchoice.com Enables Persona... Fort Washington, PA (PRWEB) De...to give consumers is to read their own medical rec...R), keeping control of personal medical records is...ton, PA based healthcare technology company has ad...
(Date:12/2/2009)... eCube Systems Achieves IBM Read...tend heritage applications to the mainframe and co... Houston, TX (PRWEB) December 2, 2009 --...pplication modernization, today announced that it ...NXTera™ high performance middleware. This m...
(Date:12/2/2009)... , SAN DIEGO, Dec. 2 ...nt at the 21st Annual Piper Jaffray Health Care Co...entation is scheduled to be webcast live and may b... of Gen-Probe,s website at www.gen-probe.com . Th...the event. ,, About Gen-Probe ,, Gen-Prob...
Breaking Medicine News(10 mins):Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 2Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 3Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 4Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 2Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 3Health News:Personal Health Records On-Demand, In Your Pocket 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 3Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2
...vative New Treatments, AMSTERDAM, December 14 Ki...ATIR has received approval for regulatory,classifi...Innovation Task,Force (ITF), a division of the Eur...for orphan drug designation with the EMEA,to obtai...
... Riversides Douglas Ethell , an assistant profess...lls die in disorders such as Alzheimers and Parkin...nt by the California Institute for Regenerative Me...yonic stem cells for treating Alzheimers disease, ...
... deal of welcome progress in the last several deca... obstructive pulmonary disease (COPD) is on the ri.... By 2000, the number of women dying from COPD sur..., The disease expression of COPD in women is diff...
...modern employment practices can put as much strain...tra 120 hours a year, an extensive study of the Br...Research Council suggests. , The research finds ... ways of extracting more effort and higher perform...
...rt of its ongoing,global campaign to lower drug pr...atments in India and worldwide, AIDS Healthcare Fo...ut recently offered in India by,generic drug manuf... pressuring Cipla to lower its prices in India --,...
... Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ) anno...tion (FDA) has granted orphan drug status to ISIS ...myotrophic lateral sclerosis (ALS),commonly referr...611, a second-generation antisense drug, is Isis,f...
Other Medicine News:Health News:ATIR Classified as "Cell Based" Medicinal Product by the EMEA 2Health News:UCR researcher awarded $2.1M stem cell grant to study Alzheimer's disease 2Health News:UCR researcher awarded $2.1M stem cell grant to study Alzheimer's disease 3Health News:When disease discriminates: Women and COPD 2Health News:When disease discriminates: Women and COPD 3Health News:Workplace opportunities and stresses are both increasing 2Health News:Workplace opportunities and stresses are both increasing 3Health News:Workplace opportunities and stresses are both increasing 4Health News:Cipla Offers Modest AIDS Drug Price Cut: 'Not Nearly Enough,' says AHF 2Health News:Cipla Offers Modest AIDS Drug Price Cut: 'Not Nearly Enough,' says AHF 3Health News:Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 2Health News:Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 3
(Date:12/1/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, Direct to Consumer (DTC) Advertising in Ph... Regulatory Landscape and Case Studies ,, htt...er-DTC-Advertising-in-Pharmaceuticals---Current-an...ase-Studies.html ,, Summary ,, The author...
(Date:12/1/2009)...wswire/ -- RoundTable Healthcare Partners, an oper...vely on the health-care industry, announced today ... sell one of its portfolio companies, Ascent Healt...("Stryker"), one of the world,s leading medical te...or to closing, Ascent will distribute $35 million ...
(Date:12/1/2009)...wswire/ -- CeloNova BioSciences, Inc., a provider ...s and of specialty implants, today announced that ...edical director of Baptist Cardiac & Vascular ...NIA(TM) Stent System with NanoThin Polyzene®-...ns Conference to be held at the Hotel David InterC...
Breaking Medicine Technology:Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 2Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 3Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 4Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 5Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 6Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 7Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 8RoundTable Healthcare Partners Announces Sale of Ascent Healthcare Solutions to Stryker Corporation 2Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv 2Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial 4970 1Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial 4970 2Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial 4970 3First results from major European patient survey show devastating impact of living with breakthrough cancer pain 56899 1First results from major European patient survey show devastating impact of living with breakthrough cancer pain 56899 2Columbia South Carolina Plastic Cosmetic Surgeon Gives his Website a State of the Art Lift 56897 1Columbia South Carolina Plastic Cosmetic Surgeon Gives his Website a State of the Art Lift 56897 2Columbia South Carolina Plastic Cosmetic Surgeon Gives his Website a State of the Art Lift 56897 3
...nd Significantly Improves Effectiveness of ...Mass., March 10 Thermo Fisher,Scientific Inc. (NY...as,developed a breakthrough gene-silencing tool th...hnology and eliminates barriers associated with,pr...xpected to accelerate,research and drug discovery ...
...al Meeting Support Longterm ... Genzyme Corp.,(Nasdaq: GENZ ), today announced ...tudy that investigated the long-term durability of... patients who had pain and,functional impairment f...ee. These findings revealed that almost 90 percent...
Other Medicine Technology:Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology 2Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology 3Genzyme Announces Presentation of New Positive Data on Carticel(R) 2Genzyme Announces Presentation of New Positive Data on Carticel(R) 3Genzyme Announces Presentation of New Positive Data on Carticel(R) 4Genzyme Announces Presentation of New Positive Data on Carticel(R) 5Genzyme Announces Presentation of New Positive Data on Carticel(R) 6
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: